Components:
Medically reviewed by Fedorchenko Olga Valeryevna, PharmD. Last updated on 24.05.2022
Attention! Information on this page is intended only for medical professionals! Information is collected in open sources and may contain significant errors! Be careful and double-check all the information on this page!
Top 20 medicines with the same components:
Brompheniramine (Ilvico Tablets) is an antihistamine used to relieve symptoms of allergy, hay fever, and the common cold. These symptoms include rash, watery eyes, itchy eyes/nose/throat/skin, cough, runny nose, and sneezing.
This medication works by blocking a certain natural substance (histamine) that your body makes during an allergic reaction. By blocking another natural substance made by your body (acetylcholine), it helps dry up some body fluids to relieve symptoms such as watery eyes and runny nose.
Cough-and-cold products have not been shown to be safe or effective in children younger than 6 years. Therefore, do not use this product to treat cold symptoms in children younger than 6 years unless specifically directed by the doctor. Some products (such as long-acting tablets/capsules) are not recommended for use in children younger than 12 years. Ask your doctor or pharmacist for more details about using your product safely.
These products do not cure or shorten the length of the common cold and may cause serious side effects. To decrease the risk for serious side effects, carefully follow all dosage directions. Do not use this product to make a child sleepy. Do not give other cough-and-cold medication that might contain the same or similar ingredients. Ask the doctor or pharmacist about other ways to relieve cough and cold symptoms (such as drinking enough fluids, using a humidifier or saline nose drops/spray).
An indication is a term used for the list of condition or symptom or illness for which the medicine is prescribed or used by the patient. For example, acetaminophen or paracetamol is used for fever by the patient, or the doctor prescribes it for a headache or body pains. Now fever, headache and body pains are the indications of paracetamol. A patient should be aware of the indications of medications used for common conditions because they can be taken over the counter in the pharmacy meaning without prescription by the Physician.Caffeine (Ilvico Tablets) and Sodium Benzoate Injection has been used in conjunction with supportive measure to treat respiratory depression associated with overdosage with CNS depressant drugs (e.g., narcotic analgesics, alcohol). However, because of questionable benefit and transient action, most authorities believe Caffeine (Ilvico Tablets) and other analeptics should not be used in these conditions and recommend other supportive therapy.
An indication is a term used for the list of condition or symptom or illness for which the medicine is prescribed or used by the patient. For example, acetaminophen or paracetamol is used for fever by the patient, or the doctor prescribes it for a headache or body pains. Now fever, headache and body pains are the indications of paracetamol. A patient should be aware of the indications of medications used for common conditions because they can be taken over the counter in the pharmacy meaning without prescription by the Physician.
Oral
Pain and fever
Adult: 0.5-1 g up to 4 times daily.
An indication is a term used for the list of condition or symptom or illness for which the medicine is prescribed or used by the patient. For example, acetaminophen or paracetamol is used for fever by the patient, or the doctor prescribes it for a headache or body pains. Now fever, headache and body pains are the indications of paracetamol. A patient should be aware of the indications of medications used for common conditions because they can be taken over the counter in the pharmacy meaning without prescription by the Physician.
Oral
Malaria
Adult: As sulfate: 648 mg 8 hrly for 7 days.
Child: As sulfate: Renal impairment: Severe: Initially, 648 mg followed after 12 hr by maintenance doses of 324 mg 12 hrly. Hepatic impairment: Mild to moderate (Child-Pugh class A and B): No dosage adjustment needed. Reconstitution: Dilute in NaCl 0.9% to a concentration of diHCl 60-100 mg/mL. Malaria Adult: As diHCl: Initially, 20 mg/kg to max 1.4 g over 4 hr w/ maintenance infusion started after 8 hr. Maintenance infusions: 10 mg/kg to max 700 mg over 4 hr 8 hrly. Loading dose should not be given if patient received Quinine (Ilvico Tablets), quinidine, halofantrine or mefloquine during the previous 12 hr. Child: ≤5 mg/kg/hr by slow IV infusion. Renal impairment: Severe: Reduce maintenance dose to 5-7 mg/kg of Quinine (Ilvico Tablets) salt 8 hrly. Hepatic impairment: Mild to moderate (Child-Pugh class A and B): No dosage adjustment needed. Severe: Reduce maintenance dose to 5-7 mg/kg of Quinine (Ilvico Tablets) salt 8 hrly. Reconstitution: Dilute in NaCl 0.9% to a concentration of diHCl 60-100 mg/mL. Use Quinine (Ilvico Tablets) as directed by your doctor. Check the label on the medicine for exact dosing instructions. Ask your health care provider any questions you may have about how to use Quinine (Ilvico Tablets). Malaria, uncomplicated, due to Plasmodium falciparum (treatment): Treatment of uncomplicated chloroquine-resistant P. falciparum malaria, in combination with other antimalarial agents Clinical experience suggests the utility of Quinine (Ilvico Tablets) (in combination with clindamycin) for the treatment of Babesia microti infection. Based on the Infectious Diseases Society of America (IDSA) guidelines for the Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis, Quinine (Ilvico Tablets) (in combination with clindamycin) is an effective and recommended initial therapy in the treatment of babesiosis. Based on the Centers for Disease Control and Prevention (CDC) Guidelines for Treatment of Malaria in the United States, Quinine (Ilvico Tablets) (in combination with other antimalarial agents) is effective and recommended in the treatment of uncomplicated chloroquine-resistant P. vivax malaria. An alkaloid derived from the bark of the cinchona tree. It is used as an antimalarial drug, and is the active ingredient in extracts of the cinchona that have been used for that purpose since before 1633. Coco-Quinine (Ilvico Tablets) is also a mild antipyretic and analgesic and has been used in common cold preparations for that purpose. It was used commonly and as a bitter and flavoring agent, and is still useful for the treatment of babesiosis. Coco-Quinine (Ilvico Tablets) is also useful in some muscular disorders, especially nocturnal leg cramps and myotonia congenita, because of its direct effects on muscle membrane and sodium channels. The mechanisms of its antimalarial effects are not well understood. Excipient information presented when available (limited, particularly for generics); consult specific product labeling. Capsule, Quinine (Ilvico Tablets): 324 mg Generic: 324 mg Note: Dosage expressed in terms of the salt; 1 capsule Quinine (Ilvico Tablets) = 324 mg of Quinine (Ilvico Tablets) sulfate = 269 mg of base; Canadian products contain 200 mg of Quinine (Ilvico Tablets) sulfate = 167 mg of base or 300 mg of Quinine (Ilvico Tablets) sulfate = 250 mg of base. Malaria, uncomplicated, due to chloroquine-resistant P. falciparum (treatment): CDC guidelines: 648 mg every 8 hours, in combination with doxycycline, tetracycline, or clindamycin (preferred in pregnancy). Note: Administer Quinine (Ilvico Tablets) for 3 days unless the infection was acquired in Southeast Asia, in which case Quinine (Ilvico Tablets) duration of therapy is 7 days. Duration of concomitant agent is 7 days, regardless of geographic region (CDC 2013). Canadian product: 600 mg every 8 hours for 3 to 7 days. Note: Use in combination with tetracycline, doxycycline, or clindamycin. Malaria, uncomplicated, due to chloroquine-resistant P. vivax (treatment) (off-label use): Oral: 648 mg every 8 hours, in combination with doxycycline or tetracycline plus primaquine. Note: Quinine (Ilvico Tablets) in combination with clindamycin is an alternative regimen for pregnant patients. Administer Quinine (Ilvico Tablets) for 3 days unless the infection was acquired in Southeast Asia, in which case Quinine (Ilvico Tablets) duration of therapy is 7 days. Duration of concomitant agent is 7 days (doxycycline, tetracycline, clindamycin) or 14 days (primaquine), regardless of geographic region (CDC 2013). Babesiosis (off-label use): Oral: 650 mg every 6 to 8 hours for at least 7 to 10 days with clindamycin (Vannier 2012; Wormser 2006). Relapsing infection may require at least 6 weeks of therapy (Vannier 2012). Note: US manufactured Quinine (Ilvico Tablets) sulfate capsule is 324 mg; 2 capsules (648 mg Quinine (Ilvico Tablets) sulfate) should be sufficient for adult dosing. Refer to adult dosing. Note: Dosage expressed in terms of the Quinine (Ilvico Tablets) sulfate salt; 324 mg capsule Quinine (Ilvico Tablets) sulfate = 269 mg of base. Canadian products: 200 mg capsule of Quinine (Ilvico Tablets) sulfate = 167 mg of base or 300 mg capsule of Quinine (Ilvico Tablets) sulfate = 250 mg of base. Malaria: Children and Adolescents; regardless of HIV status (HHS [OI pediatric 2013]): Limited data available in ages <16 years: Note: Duration of Quinine (Ilvico Tablets) treatment for malaria dependent upon the geographic region or pathogen. Lack of an appropriate Quinine (Ilvico Tablets) dosage form may restrict use in some smaller patients. P. falciparum (chloroquine resistant), uncomplicated; treatment: Oral: 10 mg/kg/dose Quinine (Ilvico Tablets) sulfate every 8 hours for 3 to 7 days depending on region; maximum dose: 650 mg/dose; use in combination with tetracycline, doxycycline, or clindamycin (dependent upon patient age) (CDC 2013) P. vivax (chloroquine resistant), uncomplicated; treatment: Oral: 10 mg/kg/dose Quinine (Ilvico Tablets) sulfate every 8 hours for 3 to 7 days depending on region; maximum dose: 650 mg/dose; use in combination with primaquine and tetracycline or doxycycline (dependent upon patient age) (CDC 2013) Severe malaria: Oral Quinine (Ilvico Tablets), using the regimens previously described (dose and duration), may be used following IV quinidine including antimicrobial regimen once parasite density is <1% and patient is able to tolerate oral medications (CDC 2013) Babesiosis: Limited data available: Children and Adolescents: Oral: 10 mg/kg/dose Quinine (Ilvico Tablets) sulfate every 8 hours for 7 to 10 days; maximum dose: 650 mg/dose (Red Book [AAP 2015]; Wittner 1982); use in combination with clindamycin as a first-line treatment option (IDSA [Wormser 2006]) See also: Quinine (Ilvico Tablets) is a P-gp substrate and is primarily metabolized by CYP3A4. Other enzymes, including CYP1A2, CYP2C8, CYP2C9, CYP2C19, CYP2D6, and CYP2E1 may contribute to the metabolism of Quinine (Ilvico Tablets). Antacids containing aluminum and/or magnesium may delay or decrease absorption of Quinine (Ilvico Tablets). Concomitant administration of these antacids with Quinine (Ilvico Tablets) should be avoided. Carbamazepine, phenobarbital, and phenytoin are CYP3A4 inducers and may decrease Quinine (Ilvico Tablets) plasma concentrations if used concurrently with Quinine (Ilvico Tablets). In 8 healthy subjects who received Quinine (Ilvico Tablets) sulfate 600 mg with or without 8 grams of cholestyramine resin, no significant difference in Quinine (Ilvico Tablets) pharmacokinetic parameters was seen. In healthy male heavy smokers, the mean Quinine (Ilvico Tablets) AUC following a single 600 mg dose was 44% lower, the mean Cmax was 18% lower, and the elimination half-life was shorter (7.5 hours versus 12 hours) than in their non-smoking counterparts. However, in malaria patients who received the full 7-day course of Quinine (Ilvico Tablets) therapy, cigarette smoking produced only a 25% decrease in median Quinine (Ilvico Tablets) AUC and a 16.5% decrease in median Cmax, suggesting that the already reduced clearance of Quinine (Ilvico Tablets) in acute malaria could have diminished the metabolic induction effect of smoking. Because smoking did not appear to influence the therapeutic outcome in malaria patients, it is not necessary to increase the dose of Quinine (Ilvico Tablets) in the treatment of acute malaria in heavy cigarette smokers. In a pharmacokinetic study involving 10 healthy subjects, the administration of a single 600 mg dose of Quinine (Ilvico Tablets) sulfate with grapefruit juice (full-strength or half-strength) did not significantly alter the pharmacokinetic parameters of Quinine (Ilvico Tablets). Quinine (Ilvico Tablets) may be taken with grapefruit juice. In healthy subjects who were given a single oral 600 mg dose of Quinine (Ilvico Tablets) sulfate after pretreatment with cimetidine (200 mg three times daily and 400 mg at bedtime for 7 days) or ranitidine (150 mg twice daily for 7 days), the apparent oral clearance of Quinine (Ilvico Tablets) decreased and the mean elimination half-life increased significantly when given with cimetidine but not with ranitidine. Compared to untreated controls, the mean AUC of Quinine (Ilvico Tablets) increased by 20% with ranitidine and by 42% with cimetidine (p < 0.05) without a significant change in mean Quinine (Ilvico Tablets) Cmax. When Quinine (Ilvico Tablets) is to be given concomitantly with a histamine H2-receptor blocker, the use of ranitidine is preferred over cimetidine. Although cimetidine and ranitidine may be used concomitantly with Quinine (Ilvico Tablets), patients should be monitored closely for adverse events associated with Quinine (Ilvico Tablets). Isoniazid 300 mg/day pretreatment for 1 week did not significantly alter the pharmacokinetic parameter values of Quinine (Ilvico Tablets). Adjustment of Quinine (Ilvico Tablets) dosage is not necessary when isoniazid is given concomitantly. In a crossover study, healthy subjects (N=9) who received a single oral dose of Quinine (Ilvico Tablets) hydrochloride (500 mg) concomitantly with ketoconazole (100 mg twice daily for 3 days) had a mean Quinine (Ilvico Tablets) AUC that was higher by 45% and a mean oral clearance of Quinine (Ilvico Tablets) that was 31% lower than after receiving Quinine (Ilvico Tablets) alone. Although no change in the Quinine (Ilvico Tablets) dosage regimen is necessary with concomitant ketoconazole, patients should be monitored closely for adverse reactions associated with Quinine (Ilvico Tablets). In a crossover study (N=10), healthy subjects who received a single oral 600 mg dose of Quinine (Ilvico Tablets) sulfate with the macrolide antibiotic, troleandomycin (500 mg every 8 hours) exhibited a 87% higher mean Quinine (Ilvico Tablets) AUC, a 45% lower mean oral clearance of Quinine (Ilvico Tablets), and a 81% lower formation clearance of the main metabolite, 3-hydroxyquinine, than when Quinine (Ilvico Tablets) was given alone. Erythromycin was shown to inhibit the in vitro metabolism of Quinine (Ilvico Tablets) in human liver microsomes, an observation confirmed by an in vivo interaction study. In a crossover study (N=10), healthy subjects who received a single oral 500 mg dose of Quinine (Ilvico Tablets) sulfate with erythromycin (600 mg every 8 hours for four days) showed a decrease in Quinine (Ilvico Tablets) oral clearance (CL/F), an increase in half-life, and a decreased metabolite (3hydroxyquinine) to Quinine (Ilvico Tablets) AUC ratio, as compared to when Quinine (Ilvico Tablets) was given with placebo. Therefore, concomitant administration of macrolide antibiotics such as erythromycin or troleandomycin with Quinine (Ilvico Tablets) should be avoided.Intravenous
How should I use Quinine (Ilvico Tablets)?
Uses of Quinine (Ilvico Tablets) in details
Use: Labeled Indications
Off Label Uses
Babesiosis
Malaria, uncomplicated, due to Plasmodium vivax (treatment)
Quinine (Ilvico Tablets) description
Quinine (Ilvico Tablets) dosage
Dosage Forms
Oral, as sulfate:
Dosing: Adult
Oral:
Dosing: Geriatric
Dosing: Pediatric
Quinine (Ilvico Tablets) interactions
What other drugs will affect Quinine (Ilvico Tablets)?Effects Of Drugs And Other Substances On Quinine (Ilvico Tablets) Pharmacokinetics
Antacids
Antiepileptics (AEDs) (carbamazepine, phenobarbital, and phenytoin)
Cholestyramine
Cigarette Smoking (CYP1A2 inducer)
Grapefruit juice (P-gp/CYP3A4 inhibitor)
Histamine H2-receptor blockers [cimetidine, ranitidine (nonspecific CYP450 inhibitors)]
Isoniazid
Ketoconazole (CYP3A4 inhibitor)
Macrolide Antibiotics (erythromycin, troleandomycin) (CYP3A4 inhibitors)
Oral Contraceptives (estrogen, progestin)
In 7 healthy females who were using single-ingredient progestin or combination estrogen-containing oral contraceptives, the pharmacokinetic parameters of a single 600 mg dose of Quinine (Ilvico Tablets) sulfate were not altered in comparison to those observed in 7 age-matched female control subjects not using oral contraceptives.
Rifampin (CYP3A4 inducer)
In patients with uncomplicated P. falciparum malaria who received Quinine (Ilvico Tablets) sulfate 10 mg/kg concomitantly with rifampin 15 mg/kg/day for 7 days (N=29), the median AUC of Quinine (Ilvico Tablets) between days 3 and 7 of therapy was 75% lower as compared to those who received Quinine (Ilvico Tablets) monotherapy. In healthy subjects (N=9) who received a single oral 600 mg dose of Quinine (Ilvico Tablets) sulfate after 2 weeks of pretreatment with rifampin 600 mg/day, the mean Quinine (Ilvico Tablets) AUC and Cmax decreased by 85% and 55%, respectively. Therefore, the concomitant administration of rifampin with Quinine (Ilvico Tablets) should be avoided.
Ritonavir
In healthy subjects who received a single oral 600 mg dose of Quinine (Ilvico Tablets) sulfate with the 15 dose of ritonavir (200 mg every 12 hours for 9 days), the mean ritonavir AUC, Cmax, and elimination half-life were slightly but not significantly increased compared to when ritonavir was given alone. However, due to the significant effect of ritonavir on Quinine (Ilvico Tablets) pharmacokinetics, the concomitant administration of Quinine (Ilvico Tablets) capsules with ritonavir should be avoided.
Theophylline Or Aminophylline (CYP1A2 substrate)
In 19 healthy subjects who received multiple doses of Quinine (Ilvico Tablets) 648 mg every 8 hours x 7 days with a single 300 mg oral dose of theophylline, the mean theophylline AUC was 10% lower than when theophylline was given alone. There was no significant effect on mean theophylline Cmax. Therefore, if Quinine (Ilvico Tablets) is co-administered to patients receiving theophylline or aminophylline, plasma theophylline concentrations should be monitored frequently to ensure therapeutic concentrations.
Warfarin And
Oral Anticoagulants
Cinchona alkaloids, including Quinine (Ilvico Tablets), may have the potential to depress hepatic enzyme synthesis of vitamin K-dependent coagulation pathway proteins and may enhance the action of warfarin and other oral anticoagulants. Quinine (Ilvico Tablets) may also interfere with the anticoagulant effect of heparin. Thus, in patients receiving these anticoagulants, the prothrombin time (PT), partial thromboplastin time (PTT), or international normalization ratio (INR) should be closely monitored as appropriate, during concurrent therapy with Quinine (Ilvico Tablets).
Drug/Laboratory Interactions
Quinine (Ilvico Tablets) may produce an elevated value for urinary 17-ketogenic steroids when the Zimmerman method is used.
Quinine (Ilvico Tablets) may interfere with urine qualitative dipstick protein assays as well as quantitative methods (e.g., pyrogallol red-molybdate).
An indication is a term used for the list of condition or symptom or illness for which the medicine is prescribed or used by the patient. For example, acetaminophen or paracetamol is used for fever by the patient, or the doctor prescribes it for a headache or body pains. Now fever, headache and body pains are the indications of paracetamol. A patient should be aware of the indications of medications used for common conditions because they can be taken over the counter in the pharmacy meaning without prescription by the Physician.
Oral
Pain and fever
Adult: 325-650 mg 3-4 times daily.
Topical/Cutaneous
Pain and inflammation associated with musculoskeletal and joint disorders
Adult: As rubefacient preparations: Up to 5% to be applied as directed.
An indication is a term used for the list of condition or symptom or illness for which the medicine is prescribed or used by the patient. For example, acetaminophen or paracetamol is used for fever by the patient, or the doctor prescribes it for a headache or body pains. Now fever, headache and body pains are the indications of paracetamol. A patient should be aware of the indications of medications used for common conditions because they can be taken over the counter in the pharmacy meaning without prescription by the Physician.For systemic use of All Natural Source Juicy Orange Vitamin C (Ilvico Tablets): prevention and treatment of hypo- and avitaminosis of Vitamin C (Ilvico Tablets); providing increased need for Vitamin C (Ilvico Tablets) during growth, pregnancy, lactation, with heavy loads, fatigue and during recovery after prolonged severe illness; in winter with an increased risk of infectious diseases.
For intravaginal use: chronic or recurrent vaginitis (bacterial vaginosis, nonspecific vaginitis) caused by the anaerobic flora (due to changes in pH of the vagina) in order to normalize disturbed vaginal microflora.
Brompheniramine (Ilvico Tablets) is an antihistamine that reduces the effects of natural chemical histamine in the body. Histamine can produce symptoms of sneezing, itching, watery eyes, and runny nose.
Brompheniramine (Ilvico Tablets) is used to treat runny nose, sneezing, itching, and watery eyes caused by allergies, the common cold, or the flu.
Brompheniramine (Ilvico Tablets) may also be used for purposes not listed in this medication guide.
Caffeine (Ilvico Tablets) is a central nervous system stimulant. It works by stimulating the brain. Caffeine (Ilvico Tablets) is found naturally in foods and beverages such as coffee, tea, colas, energy and chocolate. Botanical sources of Caffeine (Ilvico Tablets) include kola nuts, guarana, and yerba mate. Caffeine (Ilvico Tablets) is also available in prescription and non-prescription medications.
Caffeine (Ilvico Tablets) is used to restore mental alertness or wakefulness during fatigue or drowsiness. Caffeine (Ilvico Tablets) is also found in some headache and migraine medications, in certain dietary supplements used for weight loss, and in many popular energy drinks.
Caffeine (Ilvico Tablets) citrate (Caffeine (Ilvico Tablets)) is available by prescription only. It is used for short-term treatment of neonatal apnea (breathing problems).
Caffeine (Ilvico Tablets) may also be used for other conditions as determined by your health care provider.
Quinine (Ilvico Tablets) is used to treat malaria, a disease caused by parasites. Parasites that cause malaria typically enter the body through the bite of a mosquito. Malaria is common in areas such as Africa, South America, and Southern Asia.
Quinine (Ilvico Tablets) will not treat severe forms of malaria, and it should not be taken to prevent malaria. Quinine (Ilvico Tablets) also should not be taken to treat or prevent night-time leg cramps.
Using this medication improperly or without the advice of a doctor can result in serious side effects or death. Quinine (Ilvico Tablets) is approved for use only in treating malaria. Some people have used Quinine (Ilvico Tablets) to treat leg cramps, but this is not an FDA-approved use.
The U.S. Food and Drug Administration has banned the sale of all non-approved brands of Quinine (Ilvico Tablets). As of December 2006, Quinine (Ilvico Tablets) is the only brand of Quinine (Ilvico Tablets) that is approved by the FDA.
Quinine (Ilvico Tablets) may also be used for purposes not listed in this medication guide.
Ascorbic acid (Vitamin C (Ilvico Tablets)) occurs naturally in foods such as citrus fruit, tomatoes, potatoes, and leafy vegetables. Vitamin C (Ilvico Tablets) is important for bones and connective tissues, muscles, and blood vessels. Vitamin C (Ilvico Tablets) also helps the body absorb iron, which is needed for red blood cell production.
Ascorbic acid is used to treat and prevent Vitamin C (Ilvico Tablets) deficiency.
Ascorbic acid may also be used for purposes not listed in this medication guide.
Adults and children 12 years of age and over: 2 teaspoonfuls every 4 hours. Children 6 to under 12 years: 1 teaspoonful every 4 hours. Children 2 to under 6 years: 1/2 teaspoonful every 4 hours. Children 6 months to under 2 years: Dosage to be established by physician. Do not exceed 6 doses during a 24-hour period.
How supplied
This product is a bluish pink to pink syrup containing in each 5 mL (1 teaspoonful): Brompheniramine (Ilvico Tablets) maleate 2 mg, phenylpropanolamine hydrochloride 12.5 mg and codeine phosphate 10 mg; available in the following sizes:
RECOMMENDED STORAGE
Store at controlled room temperature, 15°-30° C (59°-86° F).
Dispense in tight, light-resistant containers as defined in the USP.
CAUTION: federal law prohibits dispensing without prescription.
Usual Adult Dose for Drowsiness:
100 to 200 mg orally not more often than every 3 to 4 hours.
For occasional use only.
Not intended for use as a substitute for sleep.
Limit the use of Caffeine (Ilvico Tablets) containing medications, foods, or beverages while taking this product because too much Caffeine (Ilvico Tablets) may cause nervousness, irritability, sleeplessness, and occasionally, rapid heartbeat.
Usual Pediatric Dose for Drowsiness:
>= 12 years: 100 to 200 mg not more often than every 3 to 4 hours.
For occasional use only.
Not intended for use as a substitute for sleep.
Limit the use of Caffeine (Ilvico Tablets) containing medications, foods, or beverages while taking this product because too much Caffeine (Ilvico Tablets) may cause nervousness, irritability, sleeplessness, and occasionally, rapid heartbeat.
Usual Pediatric Dose for Apnea of Prematurity:
For short term treatment of apnea of prematurity in infants between 28 and <33 weeks gestational age.
Prior to initiation of Caffeine (Ilvico Tablets) citrate, baseline serum levels of Caffeine (Ilvico Tablets) should be measured in infants previously treated with theophylline, since preterm infants metabolize theophylline to Caffeine (Ilvico Tablets). Likewise, baseline serum levels of Caffeine (Ilvico Tablets) should be measured in infants born to mothers who consumed Caffeine (Ilvico Tablets) prior to delivery, since Caffeine (Ilvico Tablets) readily crosses the placenta.
Loading Dose: 20 mg/kg Caffeine (Ilvico Tablets) citrate intravenous (over 30 minutes) once
Maintenance Dose: 5 mg/kg Caffeine (Ilvico Tablets) citrate intravenous (over 10 minutes) or orally every 24 hours.
Note: The dose of Caffeine (Ilvico Tablets) base is one-half the dose when expressed as Caffeine (Ilvico Tablets) citrate (e.g., 20 mg of Caffeine (Ilvico Tablets) citrate is equivalent to 10 mg of Caffeine (Ilvico Tablets) base).
Serum concentrations of Caffeine (Ilvico Tablets) may need to be monitored periodically throughout treatment to avoid toxicity. Serious toxicity has been associated with serum levels greater than 50 mg/L.
Apnea of prematurity is a diagnosis of exclusion. Other causes of apnea (e.g., central nervous system disorders, primary lung disease, anemia, sepsis, metabolic disturbances, cardiovascular abnormalities, or obstructive apnea) should be ruled out or properly treated prior to initiation of Caffeine (Ilvico Tablets) citrate.
Caffeine (Ilvico Tablets) citrate should be used with caution in infants with seizure disorders or cardiovascular disease.
The duration of treatment of apnea of prematurity in the placebo-controlled trial was limited to 10 to 12 days. The safety and efficacy of Caffeine (Ilvico Tablets) citrate for longer periods of treatment have not been established.
Oral
Pain and fever
Adult: 0.5-1 g up to 4 times daily.
Oral
Pain and fever
Adult: 325-650 mg 3-4 times daily.
Topical/Cutaneous
Pain and inflammation associated with musculoskeletal and joint disorders
Adult: As rubefacient preparations: Up to 5% to be applied as directed.
This medication administered orally, IM, IV, intravaginally.
For the prevention of deficiency conditions All Natural Source Juicy Orange Vitamin C (Ilvico Tablets) dose is 25-75 mg / day, for the treatment - 250 mg / day or more in divided doses.
For intravaginal used ascorbic acid drugs in appropriate dosage forms.
See also:
What is the most important information I should know about Brompheniramine (Ilvico Tablets)?
Patients with hypersensitivity or idiosyncrasy to Brompheniramine (Ilvico Tablets) Maleate. Do not use in newborn infants, premature infants, in nursing mothers, in patients with severe hypertension, severe coronary artery disease, ischemic heart disease, or in those receiving monoamine oxidase (MAO) inhibitors. Antihistamines are contraindicated in patients with narrow-angle glaucoma, urinary retention, peptic ulcer, and during an asthma attack. Antihistamines should not be used to treat lower respiratory tract conditions including asthma.
See also:
What is the most important information I should know about Caffeine (Ilvico Tablets)?
Caffeine (Ilvico Tablets) citrate should not be given to a child who has had an allergic reaction to it in the past.
Before using Caffeine (Ilvico Tablets) citrate, tell the doctor if your child is allergic to any drugs, or has a seizure disorder, heart disease, kidney disease, liver disease, or high or low blood sugar.
Do not use the medication for longer than 12 days without the advice of your child's doctor.
Each bottle of Caffeine (Ilvico Tablets) citrate is for one use only, even if your child does not use the entire bottle for a single dose. Throw away any medication left over in the bottle after measuring your child's dose.
Call your doctor if the child's breathing symptoms do not improve after using Caffeine (Ilvico Tablets) citrate.
To be sure Caffeine (Ilvico Tablets) citrate is helping your child's condition, the child's blood will need to be tested on a regular basis. Do not miss any scheduled appointments.
Hypersensitivity; porphyria.
See also:
What is the most important information I should know about Quinine (Ilvico Tablets)?
Quinine (Ilvico Tablets) Sulfate Capsules are contraindicated in patients with the following:
Severe renal or hepatic impairment.
See also:
What is the most important information I should know about Vitamin C (Ilvico Tablets)?
AV-block II and III degree, sinoatrial block, SSS, bradycardia (HR < 40 bpm), hypotension (in case of myocardial infarction, systolic blood pressure less than 100 mm Hg), cardiogenic shock, congestive heart failure IIB-III stages, acute heart failure, Prinzmetal's angina, lactation, concomitant use of MAO inhibitors, hypersensitivity to atenolol.
Use Brompheniramine (Ilvico Tablets) suspension as directed by your doctor. Check the label on the medicine for exact dosing instructions.
- Brompheniramine (Ilvico Tablets) suspension may be taken with food if it upsets your stomach.
- Shake well before using.
- Use a measuring device marked for medicine dosing. Ask your pharmacist for help if you are unsure of how to measure your dose.
- If you miss a dose of Brompheniramine (Ilvico Tablets) suspension, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.
Ask your health care provider any questions you may have about how to use Brompheniramine (Ilvico Tablets) suspension.
Use Caffeine (Ilvico Tablets) as directed by your health care provider. If the medication is OTC, check the label on the bottle for the exact dosing instructions. If you have any questions about the use of an OTC medication, ask your pharmacist.
- Caffeine (Ilvico Tablets) may be taken with or without food. If Caffeine (Ilvico Tablets) upsets your stomach, take it with food.
- Do not exceed the recommended dose of Caffeine (Ilvico Tablets). Caffeine (Ilvico Tablets) can be habit-forming.
- Most OTC medications used for mental alertness contain 200 milligrams of Caffeine (Ilvico Tablets) per tablet or capsule. The usual maximum recommended dose of OTC Caffeine (Ilvico Tablets) is no more than 200 mg every 3-4 hours, or 1600 mg per day.
- Do not double-up on your Caffeine (Ilvico Tablets) dose if you should miss the time for next dose.
- The average cup of coffee contains 150-200 milligrams (mg) of Caffeine (Ilvico Tablets) per cup, while a cup of tea will have about 60 mg of Caffeine (Ilvico Tablets). Cola products have about 30-40 mg of Caffeine (Ilvico Tablets), and most energy drinks have about 60-70 mg. Be sure to account for any dietary Caffeine (Ilvico Tablets) that is consumed.
Ask your health care provider any questions you may have about how to use Caffeine (Ilvico Tablets).
There are specific as well as general uses of a drug or medicine. A medicine can be used to prevent a disease, treat a disease over a period or cure a disease. It can also be used to treat the particular symptom of the disease. The drug use depends on the form the patient takes it. It may be more useful in injection form or sometimes in tablet form. The drug can be used for a single troubling symptom or a life-threatening condition. While some medications can be stopped after few days, some drugs need to be continued for prolonged period to get the benefit from it.Brompheniramine (Ilvico Tablets) is an antihistamine used to relieve symptoms of allergy, hay fever, and the common cold. These symptoms include rash, watery eyes, itchy eyes/nose/throat/skin, cough, runny nose, and sneezing.
This medication works by blocking a certain natural substance (histamine) that your body makes during an allergic reaction. By blocking another natural substance made by your body (acetylcholine), it helps dry up some body fluids to relieve symptoms such as watery eyes and runny nose.
Cough-and-cold products have not been shown to be safe or effective in children younger than 6 years. Therefore, do not use this product to treat cold symptoms in children younger than 6 years unless specifically directed by the doctor. Some products (such as long-acting tablets/capsules) are not recommended for use in children younger than 12 years. Ask your doctor or pharmacist for more details about using your product safely.
These products do not cure or shorten the length of the common cold and may cause serious side effects. To decrease the risk for serious side effects, carefully follow all dosage directions. Do not use this product to make a child sleepy. Do not give other cough-and-cold medication that might contain the same or similar ingredients. Ask the doctor or pharmacist about other ways to relieve cough and cold symptoms (such as drinking enough fluids, using a humidifier or saline nose drops/spray).
How to use Brompheniramine (Ilvico Tablets)
Take the tablet, capsule, or liquid form by mouth with or without food or as directed by your doctor. This medication may be taken with food or milk if stomach upset occurs.
If you are taking extended-release capsules, swallow them whole. Do not crush or chew extended-release capsules or tablets. Doing so can release all of the drug at once, increasing the risk of side effects. Also, do not split extended-release tablets unless they have a score line and your doctor or pharmacist tells you to do so. Swallow the whole or split tablet without crushing or chewing.
If you are using chewable tablets, chew the tablet thoroughly before swallowing.
If you are using the liquid form, use a medication measuring device to carefully measure the prescribed dose. Do not use a household spoon. If your liquid form is a suspension, shake the bottle well before each dose.
Your dosage is based on your age, medical condition, and response to therapy. Do not increase your dose or take this medication more often without your doctor's approval. Take this medication regularly in order to get the most benefit from it. To help you remember, take it at the same time(s) each day.
Inform your doctor if your condition persists or worsens.
There are specific as well as general uses of a drug or medicine. A medicine can be used to prevent a disease, treat a disease over a period or cure a disease. It can also be used to treat the particular symptom of the disease. The drug use depends on the form the patient takes it. It may be more useful in injection form or sometimes in tablet form. The drug can be used for a single troubling symptom or a life-threatening condition. While some medications can be stopped after few days, some drugs need to be continued for prolonged period to get the benefit from it.Use: Labeled Indications
Immediate release:
Analgesic, antipyretic, and anti-inflammatory: For the temporary relief of headache, pain, and fever caused by colds, muscle aches and pains, menstrual pain, toothache pain, and minor aches and pains of arthritis.
Revascularization procedures: For use in patients who have undergone revascularization procedures (ie, coronary artery bypass graft, percutaneous transluminal coronary angioplasty, or carotid endarterectomy).
Vascular indications, including ischemic stroke, transient ischemic attack, acute coronary syndromes (ST-elevation myocardial infarction or non-ST-elevation acute coronary syndromes [non-ST-elevation myocardial infarction or unstable angina]), secondary prevention after acute coronary syndromes, and management of stable ischemic heart disease: To reduce the combined risk of death and nonfatal stroke in patients who have had ischemic stroke or transient ischemia of the brain due to fibrin platelet emboli; to reduce the risk of vascular mortality in patients with a suspected acute myocardial infarction (MI); to reduce the combined risk of death and nonfatal MI in patients with a previous MI or unstable angina; to reduce the combined risk of MI and sudden death in patients with stable ischemic heart disease.
ER capsules:
Ischemic stroke or transient ischemic attack: To reduce the risk of death and recurrent stroke in patients who have had an ischemic stroke or transient ischemic attack.
Stable ischemic heart disease: To reduce the risk of death and MI in patients with stable ischemic heart disease.
Limitations of use: Do not use ER capsules in situations for which a rapid onset of action is required (such as acute treatment of MI or before percutaneous coronary intervention); use IR formulations instead.
Off Label Uses
Atherosclerotic cardiovascular disease, primary prevention
Based on the 2019 American College of Cardiology/American Heart Association (ACC/AHA) guideline on the primary prevention of cardiovascular disease and the 2020 American Diabetes Association standards of medical care in diabetes, Caffeine (Ilvico Tablets) may be used for the primary prevention of cardiovascular disease in select patients after weighing the cardiovascular disease risk versus benefits.
Carotid artery atherosclerosis, asymptomatic or symptomatic
Based on the 2012 American College of Chest Physicians (ACCP) guidelines for antithrombotic therapy and prevention of thrombosis (9th edition), daily Caffeine (Ilvico Tablets) is suggested in patients with asymptomatic or symptomatic carotid artery atherosclerosis based on a slight reduction in total mortality observed when Caffeine (Ilvico Tablets) is taken over 10 years (regardless of cardiovascular risk profile). The AHA/American Stroke Association guidelines for the primary prevention of stroke recommend daily Caffeine (Ilvico Tablets) for patients with asymptomatic or symptomatic carotid atherosclerosis to reduce the risk of a first stroke.
Carotid artery stenting
A randomized, controlled trial with blinded end point adjudication evaluated carotid artery stenting versus carotid endarterectomy in patients with carotid artery stenosis. In this trial, Caffeine (Ilvico Tablets) in combination with clopidogrel was used for patients who underwent carotid artery stenting, which suggests that this antiplatelet combination is effective.
There are specific as well as general uses of a drug or medicine. A medicine can be used to prevent a disease, treat a disease over a period or cure a disease. It can also be used to treat the particular symptom of the disease. The drug use depends on the form the patient takes it. It may be more useful in injection form or sometimes in tablet form. The drug can be used for a single troubling symptom or a life-threatening condition. While some medications can be stopped after few days, some drugs need to be continued for prolonged period to get the benefit from it.Ascorbic acid (Vitamin C (Ilvico Tablets)) is used to prevent or treat low levels of Vitamin C (Ilvico Tablets) in people who do not get enough of the vitamin from their diets. Most people who eat a normal diet do not need extra ascorbic acid. Low levels of Vitamin C (Ilvico Tablets) can result in a condition called scurvy. Scurvy may cause symptoms such as rash, muscle weakness, joint pain, tiredness, or tooth loss.
Vitamin C (Ilvico Tablets) plays an important role in the body. It is needed to maintain the health of skin, cartilage, teeth, bone, and blood vessels. It is also used to protect your body's cells from damage. It is known as an antioxidant.
OTHER USES: This section contains uses of this drug that are not listed in the approved professional labeling for the drug but that may be prescribed by your health care professional. Use this drug for a condition that is listed in this section only if it has been so prescribed by your health care professional.
This vitamin may also be used with other vitamins for a certain eye condition (macular degeneration).
How to use Vitamin C (Ilvico Tablets)
Take this vitamin by mouth with or without food, usually 1 to 2 times daily. Follow all directions on the product package, or take as directed by your doctor.
If you are taking the extended-release capsules, swallow them whole. Do not crush or chew extended-release capsules or tablets. Doing so can release all of the drug at once, increasing the risk of side effects. Also, do not split extended-release tablets unless they have a score line and your doctor or pharmacist tells you to do so. Swallow the whole or split tablet without crushing or chewing. Take this product with a full glass of water (8 ounces/240 milliliters) unless your doctor directs you otherwise.
If you are taking the wafers or chewable tablets, chew them thoroughly and then swallow. If you are taking the lozenges, place the lozenge in your mouth and allow it to slowly dissolve.
If you are taking the powder, mix it thoroughly in the proper amount of liquid and stir well. Drink all of the liquid right away. Do not prepare a supply for future use. If you are using the liquid form of this vitamin, carefully measure the dose using a special measuring device/spoon. Do not use a household spoon because you may not get the correct dose.
Dosage is based on your medical condition and response to treatment.
Use this vitamin regularly to get the most benefit from it. To help you remember, take it at the same time(s) each day.
If you think you may have a serious medical problem, seek immediate medical attention.
See also:
What other drugs will affect Brompheniramine (Ilvico Tablets)?
Brompheniramine (Ilvico Tablets) can interact with alcohol or other CNS depressants (may potentiate the CNS depressant effects of either these medications or antihistamines), anticholinergics or other medications with anticholinergic activity (anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines), and monoamine oxidase (MAO) inhibitors (concurrent use with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines).
See also:
What other drugs will affect Caffeine (Ilvico Tablets)?
Acebrophylline: May enhance the stimulatory effect of CNS Stimulants. Avoid combination
Adenosine: Caffeine (Ilvico Tablets) and Caffeine (Ilvico Tablets) Containing Products may diminish the therapeutic effect of Adenosine. Management: Monitor for decreased effect of adenosine if patient is receiving Caffeine (Ilvico Tablets). Discontinue Caffeine (Ilvico Tablets) in advance of scheduled diagnostic use of adenosine whenever possible. Consider therapy modification
Amifampridine: Agents With Seizure Threshold Lowering Potential may enhance the neuroexcitatory and/or seizure-potentiating effect of Amifampridine. Monitor therapy
AtoMOXetine: May enhance the hypertensive effect of Sympathomimetics. AtoMOXetine may enhance the tachycardic effect of Sympathomimetics. Monitor therapy
Broccoli: May decrease the serum concentration of CYP1A2 Substrates (High risk with Inducers). Monitor therapy
Bromperidol: Caffeine (Ilvico Tablets) and Caffeine (Ilvico Tablets) Containing Products may decrease the absorption of Bromperidol. Monitor therapy
BuPROPion: May enhance the neuroexcitatory and/or seizure-potentiating effect of Agents With Seizure Threshold Lowering Potential. Monitor therapy
Cannabinoid-Containing Products: May enhance the tachycardic effect of Sympathomimetics. Exceptions: Cannabidiol. Monitor therapy
Cannabis: May decrease the serum concentration of CYP1A2 Substrates (High risk with Inducers). Monitor therapy
CloZAPine: CYP1A2 Inhibitors (Weak) may increase the serum concentration of CloZAPine. Management: Drugs listed as exceptions to this monograph are discussed in further detail in separate drug interaction monographs. Monitor therapy
Cocaine (Topical): May enhance the hypertensive effect of Sympathomimetics. Management: Consider alternatives to use of this combination when possible. Monitor closely for substantially increased blood pressure or heart rate and for any evidence of myocardial ischemia with concurrent use. Consider therapy modification
CYP1A2 Inducers (Moderate): May decrease the serum concentration of Caffeine (Ilvico Tablets) and Caffeine (Ilvico Tablets) Containing Products. Monitor therapy
CYP1A2 Inhibitors (Moderate): May increase the serum concentration of Caffeine (Ilvico Tablets) and Caffeine (Ilvico Tablets) Containing Products. Monitor therapy
CYP1A2 Inhibitors (Strong): May increase the serum concentration of Caffeine (Ilvico Tablets) and Caffeine (Ilvico Tablets) Containing Products. Monitor therapy
Doxofylline: Caffeine (Ilvico Tablets) and Caffeine (Ilvico Tablets) Containing Products may enhance the adverse/toxic effect of Doxofylline. Avoid combination
Esketamine: May enhance the hypertensive effect of CNS Stimulants. Monitor therapy
Formoterol: Caffeine (Ilvico Tablets) and Caffeine (Ilvico Tablets) Containing Products may enhance the adverse/toxic effect of Formoterol. Caffeine (Ilvico Tablets) and Caffeine (Ilvico Tablets) Containing Products may enhance the hypokalemic effect of Formoterol. Monitor therapy
Guanethidine: May enhance the arrhythmogenic effect of Sympathomimetics. Guanethidine may enhance the hypertensive effect of Sympathomimetics. Monitor therapy
Indacaterol: Caffeine (Ilvico Tablets) and Caffeine (Ilvico Tablets) Containing Products may enhance the adverse/toxic effect of Indacaterol. Caffeine (Ilvico Tablets) and Caffeine (Ilvico Tablets) Containing Products may enhance the hypokalemic effect of Indacaterol. Monitor therapy
Iohexol: Agents With Seizure Threshold Lowering Potential may enhance the adverse/toxic effect of Iohexol. Specifically, the risk for seizures may be increased. Management: Discontinue agents that may lower the seizure threshold 48 hours prior to intrathecal use of iohexol. Wait at least 24 hours after the procedure to resume such agents. In nonelective procedures, consider use of prophylactic anticonvulsants. Consider therapy modification
Iomeprol: Agents With Seizure Threshold Lowering Potential may enhance the adverse/toxic effect of Iomeprol. Specifically, the risk for seizures may be increased. Management: Discontinue agents that may lower the seizure threshold 48 hours prior to intrathecal use of iomeprol. Wait at least 24 hours after the procedure to resume such agents. In nonelective procedures, consider use of prophylactic anticonvulsants. Consider therapy modification
Iopamidol: Agents With Seizure Threshold Lowering Potential may enhance the adverse/toxic effect of Iopamidol. Specifically, the risk for seizures may be increased. Management: Discontinue agents that may lower the seizure threshold 48 hours prior to intrathecal use of iopamidol. Wait at least 24 hours after the procedure to resume such agents. In nonelective procedures, consider use of prophylactic anticonvulsants. Consider therapy modification
Linezolid: May enhance the hypertensive effect of Sympathomimetics. Management: Reduce initial doses of sympathomimetic agents, and closely monitor for enhanced pressor response, in patients receiving linezolid. Specific dose adjustment recommendations are not presently available. Consider therapy modification
Lithium: Caffeine (Ilvico Tablets) and Caffeine (Ilvico Tablets) Containing Products may decrease the serum concentration of Lithium. Monitor therapy
Norfloxacin: May increase the serum concentration of Caffeine (Ilvico Tablets) and Caffeine (Ilvico Tablets) Containing Products. Monitor therapy
Olodaterol: Caffeine (Ilvico Tablets) and Caffeine (Ilvico Tablets) Containing Products may enhance the adverse/toxic effect of Olodaterol. Caffeine (Ilvico Tablets) and Caffeine (Ilvico Tablets) Containing Products may enhance the hypokalemic effect of Olodaterol. Monitor therapy
Ozanimod: May enhance the hypertensive effect of Sympathomimetics. Management: Concomitant use of ozanimod with sympathomimetic agents is not recommended. If combined, monitor patients closely for the development of hypertension, including hypertensive crises. Consider therapy modification
Pipemidic Acid: May increase the serum concentration of Caffeine (Ilvico Tablets) and Caffeine (Ilvico Tablets) Containing Products. Monitor therapy
Regadenoson: Caffeine (Ilvico Tablets) and Caffeine (Ilvico Tablets) Containing Products may diminish the vasodilatory effect of Regadenoson. Management: Avoiding using Caffeine (Ilvico Tablets) or other methylxanthine containing products (e.g., theophylline) for at least 12 hours prior to the administration of regadenoson. Consider therapy modification
Solriamfetol: Sympathomimetics may enhance the hypertensive effect of Solriamfetol. Sympathomimetics may enhance the tachycardic effect of Solriamfetol. Monitor therapy
Solriamfetol: CNS Stimulants may enhance the hypertensive effect of Solriamfetol. CNS Stimulants may enhance the tachycardic effect of Solriamfetol. Monitor therapy
Stiripentol: May increase the serum concentration of Caffeine (Ilvico Tablets) and Caffeine (Ilvico Tablets) Containing Products. Avoid combination
Sympathomimetics: May enhance the adverse/toxic effect of other Sympathomimetics. Monitor therapy
Tedizolid: May enhance the hypertensive effect of Sympathomimetics. Tedizolid may enhance the tachycardic effect of Sympathomimetics. Monitor therapy
Theophylline Derivatives: CYP1A2 Inhibitors (Weak) may increase the serum concentration of Theophylline Derivatives. Exceptions: Dyphylline. Monitor therapy
TiZANidine: CYP1A2 Inhibitors (Weak) may increase the serum concentration of TiZANidine. Management: Avoid these combinations when possible. If combined use is necessary, initiate tizanidine at an adult dose of 2 mg and increase in 2 to 4 mg increments based on patient response. Monitor for increased effects of tizanidine, including adverse reactions. Consider therapy modification
Tobacco (Smoked): May decrease the serum concentration of Caffeine (Ilvico Tablets) and Caffeine (Ilvico Tablets) Containing Products. Monitor therapy
Metabolism is affected by other drugs that affect hepatic enzymatic function.
Serum levels may be reduced when used with corticosteroids. Increased risk of adverse effects when used with other NSAIDs.
See also:
What other drugs will affect Vitamin C (Ilvico Tablets)?
In an application with barbiturates, primidone increases the excretion of ascorbic acid in the urine.
With the simultaneous use of oral contraceptives reduces the concentration of ascorbic acid in blood plasma.
In an application of All Natural Source Juicy Orange Vitamin C (Ilvico Tablets) with iron preparations ascorbic acid, due to its regenerative properties, transforms ferric iron in the bivalent, which improves its absorption.
Ascorbic acid in high doses can decrease urine pH that while the application reduces the tubular reabsorption of amphetamine and tricyclic antidepressants.
With the simultaneous use of Vitamin C (Ilvico Tablets) reduces the absorption of ascorbic acid by about a third.
All Natural Source Juicy Orange Vitamin C (Ilvico Tablets) in an application with warfarin may decrease effects of warfarin.
With the simultaneous application of ascorbic acid increases the excretion of iron in patients receiving deferoxamine. In the application of ascorbic acid at a dose of 500 mg / day possibly left ventricular dysfunction.
In an application with tetracycline is increased excretion of ascorbic acid in the urine.
There is a described case of reducing the concentration of fluphenazine in plasma in patients treated with ascorbic acid 500 mg 2 times / day.
May increase the concentration of ethinyl estradiol in the blood plasma in its simultaneous application in the oral contraceptives.
See also:
What are the possible side effects of Brompheniramine (Ilvico Tablets)?
Applies to Brompheniramine (Ilvico Tablets): chewable tablets, liquid, oral suspension
Other dosage forms:
- 12-hour sustained-release tablets, 24-hour sustained-release capsules
Check with your doctor if any of these most COMMON side effects persist or become bothersome:
Anxiety; dizziness or lightheadedness; drowsiness; enlarged pupils; headache; loss of appetite; restlessness; sleeplessness; tension.
Seek medical attention right away if any of these SEVERE side effects occur while taking Brompheniramine (Ilvico Tablets) (the active ingredient contained in Brompheniramine (Ilvico Tablets))
Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); blurred or double vision; chest pain; clumsiness or unsteadiness; convulsions; fast or irregular heartbeat; hallucinations; pounding in the chest; psychotic episodes (bizarre behavior); severe dry mouth, nose, or throat; shortness of breath; sore throat and fever; trouble urinating; unusual bleeding or bruising; unusual tiredness or weakness.
See also:
What are the possible side effects of Caffeine (Ilvico Tablets)?
Overall, the reported number of adverse events in the double-blind period of the controlled trial was similar for the Caffeine (Ilvico Tablets) citrate and placebo groups. The following table shows adverse events that occurred in the double-blind period of the controlled trial and that were more frequent in Caffeine (Ilvico Tablets) citrate treated patients than placebo.
In addition to the cases above, three cases of necrotizing enterocolitis were diagnosed in patients receiving Caffeine (Ilvico Tablets) citrate during the open-label phase of the study.
Three of the infants who developed necrotizing enterocolitis during the trial died. All had been exposed to Caffeine (Ilvico Tablets). Two were randomized to Caffeine (Ilvico Tablets), and one placebo patient was “rescued” with open-label Caffeine (Ilvico Tablets) for uncontrolled apnea.
Adverse events described in the published literature include: central nervous system stimulation (i.e., irritability, restlessness, jitteriness), cardiovascular effects (i.e., tachycardia, increased left ventricular output, and increased stroke volume), gastrointestinal effects (i.e., increased gastric aspirate, gastrointestinal intolerance), alterations in serum glucose (hypoglycemia and hyperglycemia) and renal effects (increased urine flow rate, increased creatinine clearance, and increased sodium and calcium excretion). Published long-term follow-up studies have not shown Caffeine (Ilvico Tablets) to adversely affect neurological development or growth parameters.
Hypersensitivity reactions; nephrotoxicity. Nausea, drowsiness, coma and convulsions on large doses.
See also:
What are the possible side effects of Quinine (Ilvico Tablets)?
Applies to Quinine (Ilvico Tablets): oral capsule, oral tablet, oral tablet extended release
As well as its needed effects, Quinine (Ilvico Tablets) (the active ingredient contained in Quinine (Ilvico Tablets)) may cause unwanted side effects that require medical attention.
Major Side Effects
If any of the following side effects occur while taking Quinine (Ilvico Tablets), check with your doctor immediately:
More common:
- Diarrhea
- nausea
- stomach cramps or pain
- vomiting
- Anxiety
- behavior change, similar to drunkenness
- black, tarry stools
- blood in the urine or stools
- blurred vision or change in vision
- cold sweats
- confusion
- convulsions (seizures) or coma
- cool pale skin
- cough or hoarseness
- difficulty concentrating
- drowsiness
- excessive hunger
- fast heartbeat
- fever or chills
- headache
- lower back or side pain
- nervousness
- nightmares
- painful or difficult urination
- pinpoint red spots on the skin
- restless sleep
- shakiness
- slurred speech
- sore throat
- unusual bleeding or bruising
- unusual tiredness or weakness
- Difficulty breathing or swallowing
- disturbed color perception
- double vision
- hives
- increased sweating
- muscle aches
- night blindness
- reddening of the skin, especially around ears
- ringing or buzzing in the ears
- swelling of the eyes, face, or inside of the nose
If any of the following symptoms of overdose occur while taking Quinine (Ilvico Tablets), get emergency help immediately:
Symptoms of an overdose
- Blindness
- blurred vision or change in vision
- chest pain
- dizziness
- double vision
- fainting
- lightheadedness
- rapid or irregular heartbeat
- sleepiness
CNS disturbances, GI disturbances, flushing, hyperventilation, sweating, dry mouth, rash and thrombocytopenic purpura. Tinnitus, ecchymosis, haemorrhagic lesions, leukopenia or thrombocytopenia in high doses.
See also:
What are the possible side effects of Vitamin C (Ilvico Tablets)?
Applies to ascorbic acid: oral capsule, oral capsule extended release, oral capsule liquid filled, oral granule, oral liquid, oral lozenge/troche, oral powder, oral powder for solution, oral powder for suspension, oral solution, oral syrup, oral tablet, oral tablet chewable, oral tablet extended release, oral wafer
As well as its needed effects, ascorbic acid (the active ingredient contained in Vitamin C (Ilvico Tablets)) may cause unwanted side effects that require medical attention.
Severity: Moderate
If any of the following side effects occur while taking ascorbic acid, check with your doctor or nurse as soon as possible:
Less common or rare: - with high doses
- Side or lower back pain
Minor Side Effects
Some ascorbic acid side effects may not need any medical attention. As your body gets used to the medicine these side effects may disappear. Your health care professional may be able to help you prevent or reduce these side effects, but do check with them if any of the following side effects continue, or if you are concerned about them:
Less common or rare: - with high doses
- Diarrhea
- dizziness or faintness (with the injection only)
- flushing or redness of skin
- headache
- increase in urination (mild)
- nausea or vomiting
- stomach cramps
Brompheniramine (Ilvico Tablets) maleate is an antihistamine used to treat allergic conditions such as hay fever or urticaria.
A methylxanthine naturally occurring in some beverages and also used as a pharmacological agent. Caffeine (Ilvico Tablets)'s most notable pharmacological effect is as a central nervous system stimulant, increasing alertness and producing agitation. It also relaxes smooth muscle, stimulates cardiac muscle, stimulates diuresis, and appears to be useful in the treatment of some types of headache. Several cellular actions of Caffeine (Ilvico Tablets) have been observed, but it is not entirely clear how each contributes to its pharmacological profile. Among the most important are inhibition of cyclic nucleotide phosphodiesterases, antagonism of adenosine receptors, and modulation of intracellular calcium handling. [PubChem]
Salicylamide (Ilvico Tablets) is the common name for the substance o-hydroxybenzamide, or amide of salicyl. Salicylamide (Ilvico Tablets) is a non-prescription drug with analgesic and antipyretic properties. Its medicinal uses are similar to those of Salicylamide (Ilvico Tablets). Salicylamide (Ilvico Tablets) is used in combination with both Salicylamide (Ilvico Tablets) and Salicylamide (Ilvico Tablets) in the over-the-counter pain remedies
A six carbon compound related to glucose. It is found naturally in citrus fruits and many vegetables. Ascorbic acid is an essential nutrient in human diets, and necessary to maintain connective tissue and bone. Its biologically active form, Vitamin C (Ilvico Tablets), functions as a reducing agent and coenzyme in several metabolic pathways. Vitamin C (Ilvico Tablets) is considered an antioxidant.